Europe grants marketing approval of Truvada for use as PrEP...


AVERT | 2017-06-16 15:44 UTC

European Commission has given pharmaceutical company, Gilead, the green light to market Truvada as pre-exposure prophylaxis (PrEP) across the region

By AVERT on 2017-06-16 15:44 UTC
  • Need an account?  
    or